Chan et al., “New-N- and )O -Arylations with Phenylboronic Acids and Cupric Acetate”, Tetrahedron Letters 39:2933-2936 (1998). |
Steele et al., CSG 26214, “The Thyroxine Connection Revisited”, Atherosclerosis X 321-324 (1995). |
Stephan, et al., “Demonstration of Potent Lipid-Lowering Activity By Athyromimetic Agent Devoid of Cardiovascular and Thermogenic Agents”, Atherosclerosis 126: 53-63 (1996). |
Underwood, et al., “A Thyromimetic that Decreases Plasma Cholesterol Levels Without Increasing Cardiac Acitivty”, Nature 324:425-429 (1986). |
Yokoyama, N. et al., “Synthesis and Structure—Activity Relationships of Oxamic Acid and Acetic Acid Derivatives Related to L-Thyronine”, J. Med. Chem 38 (4) 695-707 (1995). |
Taylor A.H. et al., “Beneficial Effects of a Novel Thyromometic on Lipoprotein Metabolism”, Molecular Pharmacology, 52: 542-547 (1997). |
Stanton, J. L. et al., “Synthesis and Biological Activity of Phenoxyphenyl Oxamic Related to L-Thyronine”, Bioorganic & Medicinal Chemistry Letters, 10: 1661-1663 (2000). |